DK0966532T3 - Biologisk materiale til behandling af et pattedyr ved antistofgenoverföring og farmaceutisk præparat indeholdende dette - Google Patents

Biologisk materiale til behandling af et pattedyr ved antistofgenoverföring og farmaceutisk præparat indeholdende dette

Info

Publication number
DK0966532T3
DK0966532T3 DK98903075T DK98903075T DK0966532T3 DK 0966532 T3 DK0966532 T3 DK 0966532T3 DK 98903075 T DK98903075 T DK 98903075T DK 98903075 T DK98903075 T DK 98903075T DK 0966532 T3 DK0966532 T3 DK 0966532T3
Authority
DK
Denmark
Prior art keywords
mammal
biological material
nucleic acid
acid sequence
gene
Prior art date
Application number
DK98903075T
Other languages
Danish (da)
English (en)
Inventor
Marc Piechaczyk
Daniele Noel
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of DK0966532T3 publication Critical patent/DK0966532T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK98903075T 1997-01-20 1998-01-16 Biologisk materiale til behandling af et pattedyr ved antistofgenoverföring og farmaceutisk præparat indeholdende dette DK0966532T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9700540A FR2758569B1 (fr) 1997-01-20 1997-01-20 Materiel biologique pour le traitement d'un mammifere par transfert de gene d'anticorps et composition pharmaceutique le concernant
PCT/FR1998/000081 WO1998031808A1 (fr) 1997-01-20 1998-01-16 Materiel biologique pour le traitement d'un mammifere par transfert de gene d'anticorps et composition pharmaceutique le contenant

Publications (1)

Publication Number Publication Date
DK0966532T3 true DK0966532T3 (da) 2007-07-30

Family

ID=26233268

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98903075T DK0966532T3 (da) 1997-01-20 1998-01-16 Biologisk materiale til behandling af et pattedyr ved antistofgenoverföring og farmaceutisk præparat indeholdende dette

Country Status (8)

Country Link
EP (1) EP0966532B1 (de)
AT (1) ATE357520T1 (de)
DE (1) DE69837380T2 (de)
DK (1) DK0966532T3 (de)
ES (1) ES2285755T3 (de)
FR (1) FR2758569B1 (de)
PT (1) PT966532E (de)
WO (1) WO1998031808A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261281B1 (en) 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
FR2784997A1 (fr) * 1998-10-22 2000-04-28 Transgene Sa Materiel biologique pour la preparation de compositions pharmaceutiques destinees au traitement de mammiferes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04507041A (ja) * 1988-12-13 1992-12-10 アメリカ合衆国 遺伝工学により修飾された内皮細胞およびその利用方法
FR2706486B1 (fr) * 1993-06-16 1995-09-01 Rhone Poulenc Rorer Sa Séquences nucléiques, vecteurs les contenant, compositions pharmaceutiques et utilisations thérapeutiques.

Also Published As

Publication number Publication date
EP0966532A1 (de) 1999-12-29
FR2758569A1 (fr) 1998-07-24
EP0966532B1 (de) 2007-03-21
ES2285755T3 (es) 2007-11-16
WO1998031808A1 (fr) 1998-07-23
DE69837380D1 (de) 2007-05-03
FR2758569B1 (fr) 1999-04-02
DE69837380T2 (de) 2007-11-29
ATE357520T1 (de) 2007-04-15
PT966532E (pt) 2007-06-29

Similar Documents

Publication Publication Date Title
RU2207878C2 (ru) "очеловеченные" антитела против gp39 человека, композиции, содержащие эти антитела, и их терапевтическое использование
FR19C1020I1 (fr) Nouvelles molecules b7-4 et leurs utilisations
DE60035517D1 (de) Gl50 moleküle, sowie verwendungen derselben
FI820075L (fi) Rekombination-dna-medel och foerfarande
SI1583830T1 (sl) Postopek za pripravo rekombinantnih poliklonskih proteinov
EP1633784A4 (de) Ovr110-antikörperzusammensetzungen und anwendungsverfahren
ZA958444B (en) Biological active proteins
LU91237I2 (fr) Palifermin et ses dérivés pharmaceutiquement acceptables (kepivance)
WO2000006705A3 (de) Genetisch modifizierte cd34-negative, adhärent wachsende stammzellen und deren verwendung in der gentherapie
DE69230993D1 (de) Rekombinante viren vektoren zur expression in muskelzellen
DK0568537T3 (da) Genetisk modificering af endotelceller
ATE132197T1 (de) Monoklonale antikörper
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
ES2054612T3 (es) Secuencias de adn que codifican para proteinas con actividad biologica de los inhibidores husi tipo-i y procedimientos tecnologicos geneticos para la preparacion de estas proteinas.
DK0781344T3 (da) Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme
EP1344821A4 (de) Neue aggrecanase
AU754505C (en) Biological material for preparing pharmaceutical compositions for treating mammals
FR2758569B1 (fr) Materiel biologique pour le traitement d'un mammifere par transfert de gene d'anticorps et composition pharmaceutique le concernant
SE0000597D0 (sv) Novel antibody
ATE265526T1 (de) Genetisch veränderte fibroblasten und ihre verwendung
ATE331794T1 (de) Humane prostacyclinsynthase
ATE58397T1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
WO2002088375A3 (en) Compositions and methods relating to breast specific genes and proteins
Dreesen et al. A peptide-reactive antibody to a Balbiani ring gene product: immunological evidence that a 6.5-kb RNA in Chironomus tentans salivary glands is mRNA for a 180-kDa nonfibrous component of larval secretion
DE60137222D1 (de) Humanes trp-ähnliches kalziumkanalprotein-2 tlcc-2